Print Page   |   Sign In   |   Join Today
Medicare Part B
Share |

Virginia Bio opposes a cut to Medicare Part B, as such a cut will limit healthcare access for the most vulnerable patients in our population.

Medicare Part B coverage of drugs provides an invaluable route of access for patients facing chronic illness. Part B provides an important pathway for patients to access a narrowly defined, limited number of provider-administered products (e.g., those that are injected or infused under the direction of a physician). Furthermore, the patients served under Part B are often the sickest and, therefore, most vulnerable.

When you communicate with your Members of Congress, please indicate your support for maintaining Medicare Part B as is. It is always vulnerable, and a perennial concern.

View Medicare Part B Primer
more Events

Charlottesville Biotech & Beer

Southwest Virginia Life Science Forum 2018

Premium Members

Membership Software Powered by YourMembership  ::  Legal